last authored: April 2009, David LaPierre
last reviewed:
Myasthenia gravis (MG) is an acquired autoimune disorder affecting the neuromuscular junction.
a simple case introducing clincial presentation and calling for a differential diagnosis. To get students thinking.
MG is caused by autoantibodies directed at the acetylcholine receptor (AChR), leading to receptor deficiency. Circulating antibodies are present in 70-80% of patients. Other antibodies may be present against muscle-specific tyrosine kinase or striate muscle itself.
Incidence is 2-5 per million, and prevalence is 13-64 per million. Female to male ratio is 6:4. MG can occur at any age, but peaks in the 3rd decade for women and in the 6th-7th decade for men.
Two-thirds of patients have thymic hyperplasia, and 10-15% have thymoma. In approximately 10% of patients, MG is associated with another autoimmune disease.
The deposition of IgG and complement at the postsynaptic membrane leads to blockage of ACh binding and AChR destruction.
Ptosis is weakness and sagging of the eyelids caused by CN III weakness, as this nerve is responsible for eyelid opening.
MG can selectively affect the external ocular muscles (ocular MG) or the entire muscle system (generalized MG).
Symptoms tend to fluctuate, being worse in the day. They can be provoked or worsened by exertion, infections, menses, and stress.
Ocular involvement is typically bilateral, assymetric, and associated with ptosis and diplopia. Weakness in facial muscles results in a loss of facial expression, a smile resembling a snarl, nasal regurgitation of liquids, choking, and slurred, nasal speech. Fatigability of limb muscles can lead to difficulties combing hair, lifting objects repeatedly, climbing stairs, walking, and running.
Fatigue is most reliably demonstrated in the eyes. The curtain sign describes worsening ptosis with upgaze, or asymmetric nystagmus on extreme lateral or medial gaze.
Proximal limb muscles tend to be more affected than distal muscles.
AChR antibody testing is positive in almost everyone with severe MG, 80% of people with mild generalized MG, and 50% of people with ocular MG. Other antibodies may be present against muscle-specific tyrosine kinase (MuSK), or against striated muscle.
Edophonium can be given 2mg IV over 15 seconds, with another 8mg injected if no response is seen over 30-45 seconds. Evaluation of muscle response should be done in areas not influenced by motivation, such as degree of ptosis or occular eye movements. Caution must be used in patients with cardiac disease to avoid bradycardia, AV block, or cardiac arrest. It should not be used in patients with respiratory distress.
EMG testing of a motor nerve at 2-3 Hz results in >10% decrease in signal amplitude after 5 tests. At least two proximal and at least two distal muscles should be tested.
CXR and CT can be useful in detecting thymomas.
Symptoms remain ocular for only 15% of patients, and when the disease becomes generalized, it usually does so within one year of onset.
authors:
reviewers: